Prana Biotechnology Ltd (PBT):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Prana Biotechnology Ltd (PBT) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C12410
◆発行会社(調査会社):GlobalData
◆発行日:2018年12月
◆ページ数:23
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オーストラリア
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Prana Biotechnology Ltd (Prana Biotech) is a developer of therapeutic drugs. The company is conducting research into Huntington disease, Alzheimer’s disease and brain cancer, and other major age-related degenerative disorders. It is developing first-in-class therapies for the treatment of neurodegenerative disease. Prana Biotech develops technology platform in association with various institutions and medical institutes. The company also maintains a library of metal protein attenuating compounds that may support new therapies for neurodegenerative disease. It also conducts various clinical programs. The company develops proprietary library of MPACs. It collaborates with various universities for its research projects. Prana Biotech is headquartered in Melbourne, Victoria, Australia.

Prana Biotechnology Ltd (PBT) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Prana Biotechnology Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Prana Biotechnology Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Prana Biotechnology Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Prana Biotechnology Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Prana Biotechnology Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Prana Biotechnology Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Prana Biotech Enters into Research Agreement with Takeda Pharma 10
Equity Offering 11
Prana Biotech Plans to Raise upto USD50 Million in Public Offering of Securities 11
Prana Biotech Completes Second Tranche Of Private Placement Of Shares For US$6 Million 12
Prana Biotechnology Announces Public Offering Of American Depositary Receipts For US$47.2 Million 13
Prana Biotech Completes Rights Offering Of Shares For US$2.1 Million 14
Prana Biotech Raises USD7.3 Million in Private Placement of Shares 15
Prana Biotech Completes Private Placement Of Shares For US$6 Million 16
Prana Biotech Completes Private Placement Of Shares For US$0.4 Million 17
Prana Biotech Completes Private Placement Of Shares For US$0.2 Million 18
Prana Biotechnology Ltd – Key Competitors 19
Prana Biotechnology Ltd – Key Employees 20
Prana Biotechnology Ltd – Locations And Subsidiaries 21
Head Office 21
Recent Developments 22
Corporate Communications 22
Jun 05, 2017: Prana Appoints David Stamler as Chief Medical Officer to Lead Clinical Development 22
Appendix 23
Methodology 23
About GlobalData 23
Contact Us 23
Disclaimer 23

List of Tables
Prana Biotechnology Ltd, Pharmaceuticals & Healthcare, Key Facts, 2018 2
Prana Biotechnology Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Prana Biotechnology Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Prana Biotechnology Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Prana Biotechnology Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Prana Biotechnology Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Prana Biotech Enters into Research Agreement with Takeda Pharma 10
Prana Biotech Plans to Raise upto USD50 Million in Public Offering of Securities 11
Prana Biotech Completes Second Tranche Of Private Placement Of Shares For US$6 Million 12
Prana Biotechnology Announces Public Offering Of American Depositary Receipts For US$47.2 Million 13
Prana Biotech Completes Rights Offering Of Shares For US$2.1 Million 14
Prana Biotech Raises USD7.3 Million in Private Placement of Shares 15
Prana Biotech Completes Private Placement Of Shares For US$6 Million 16
Prana Biotech Completes Private Placement Of Shares For US$0.4 Million 17
Prana Biotech Completes Private Placement Of Shares For US$0.2 Million 18
Prana Biotechnology Ltd, Key Competitors 19
Prana Biotechnology Ltd, Key Employees 20

List of Figures
Prana Biotechnology Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Prana Biotechnology Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Prana Biotechnology Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Prana Biotechnology Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Prana Biotechnology Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Prana Biotechnology Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Prana Biotechnology Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Prana Biotechnology Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Prana Biotechnology Ltd (PBT):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Avidity Biosciences LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary Avidity Biosciences LLC (Avidity Biosciences), formerly Avidity NanoMedicines LLC is a biotech company that develops antibody oligonucleotide conjugates (AOCs). The company’s proprietary platform technology has enhanced pharmacokinetic and biodistribution properties that improves the deliver …
  • Kuwait Investment Authority:電力:M&Aディール及び事業提携情報
    Summary The Kuwait Investment Authority (KIA) is an asset management company. It offers fund management and investment management services. The company is responsible for the management and administration of the General Reserve Fund (GRF), apart from the assets of the Future Generations Fund (FGF). …
  • Kainos Medicine Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Kainos Medicine Inc (Kainos) is a drug discovery and development company that develops drugs and medicines for cancer, brain disease, metabolic and infectious diseases. The company offers antiviral drugs, Parkinson’s drugs, HIV drugs, anticancer drugs and HBV medications. Its anticancer drug …
  • ANGLE plc (AGL):企業の製品パイプライン分析2018
    Summary ANGLE Plc (ANGLE) is a medical diagnostic company that offers cancer diagnostics and foetal health products. The company develops products for use in rare cell diagnostics that enable early, accurate identification of an individual’s condition for the prevention, treatment, and monitoring of …
  • Fujifilm SonoSite Inc:企業の戦略的SWOT分析
    Fujifilm SonoSite Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Riemser Pharma GmbH:製薬・医療:M&Aディール及び事業提携情報
    Summary Riemser Pharma GmbH (Riemser), formerly Riemser Arzneimittel AG is a distributor of lifecycle management products. The company offers analgesics products, cardiovascular products, over-the-counter medicines, prescription drugs and dental products. It provides medical products for the treatme …
  • Australian Postal Corporation:企業の戦略的SWOT分析
    Australian Postal Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • British American Tobacco Plc (BATS):企業の財務・戦略的SWOT分析
    British American Tobacco Plc (BATS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Audentes Therapeutics Inc (BOLD):企業の財務・戦略的SWOT分析
    Summary Audentes Therapeutics Inc (Audentes) is a biotechnology company. It focuses on the development and commercialization of gene therapy products for rare diseases. The company’s pipeline products include AT132, intended for the treatment of X-linked myotubular myopathy; AT982, for the treatment …
  • Southern Travel Holdings Limited:企業の戦略・SWOT・財務分析
    Southern Travel Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary Southern Travel Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Civica Group Limited:企業の戦略的SWOT分析
    Civica Group Limited - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Veracyte Inc (VCYT):医療機器:M&Aディール及び事業提携情報
    Summary Veracyte Inc (Veracyte) is a molecular diagnostics company that uses genomic technology to resolve diagnostic ambiguity. The company’s pipeline products include Afirma thyroid FNA analysis for the diagnosis of thyroid cancer based on its proprietary afirma gene expression classifier. It also …
  • BrightPath Early Learning Inc.:企業の戦略的SWOT分析
    BrightPath Early Learning Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • Pacific Hydro Pty Ltd:電力:M&Aディール及び事業提携情報
    Summary Pacific Hydro Pty Ltd (Pacific Hydro), a subsidiary of State Power Investment Corporation is an energy solutions provider that undertakes the development and operations of the renewable power projects. The company offers wind, hydro, solar and geothermal power projects at varying stages of d …
  • Carl Zeiss AG:企業の戦略的SWOT分析
    Carl Zeiss AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Petroleum, Oil and Gas Corporation of South Africa (SOC) Ltd-石油・ガス分野:企業M&A・提携分析
    Summary Petroleum, Oil and Gas Corporation of South Africa (SOC) Ltd (PetroSA) a subsidiary of CEF SOC Limited, is an integrated oil and gas company. It explores and produces oil and natural gas resources. The company operates Jubilee, Oribi, and Oryx oil fields; F-A and F-A Satellite, E-M and E-M S …
  • Gibson Energy Inc (GEI):企業の財務・戦略的SWOT分析
    Gibson Energy Inc (GEI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • J. Front Retailing Co., Ltd.:戦略・SWOT・企業財務分析
    J. Front Retailing Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary J. Front Retailing Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • BioMarin Pharmaceutical Inc.:企業の戦略・SWOT・財務分析
    BioMarin Pharmaceutical Inc. - Strategy, SWOT and Corporate Finance Report Summary BioMarin Pharmaceutical Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Transfield Holdings Pty Ltd:企業の戦略的SWOT分析
    Transfield Holdings Pty Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆